Control over HIV-1 replication by an antibiotic; a novel vaccination strategy with a drug-dependent virus.
Berkhout
Ben
B
Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, The Netherlands. b.berkhout@amc.uva.nl
Marzio
Giuseppe
G
Verhoef
Koen
K
D016915:AIDS Vaccines / Q000235:genetics* / Q000276:immunology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003257:Consumer Product Safety; D004318:Doxycycline / Q000494:pharmacology*; D019143:Evolution, Molecular; D015696:Gene Products, tat / Q000235:genetics / Q000378:metabolism; D014644:Genetic Variation; D015658:HIV Infections / Q000517:prevention & control*; D016325:HIV Long Terminal Repeat; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D006801:Humans; D014611:Vaccination / Q000379:methods*; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology; D019444:Vaccines, DNA / Q000235:genetics* / Q000276:immunology; D014779:Virus Replication / Q000187:drug effects*; D054322:tat Gene Products, Human Immunodeficiency Virus
D016915:AIDS Vaccines; D000900:Anti-Bacterial Agents; D015696:Gene Products, tat; D014613:Vaccines, Attenuated; D019444:Vaccines, DNA; D054322:tat Gene Products, Human Immunodeficiency Virus; D004318:Doxycycline